Medexus Pharmaceuticals Inc
TSX:MDP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medexus Pharmaceuticals Inc
TSX:MDP
|
CA |
|
B
|
Britannia Life Sciences Inc
CNSX:BLAB
|
CA |
|
B
|
Brainbees Solutions Ltd
NSE:FIRSTCRY
|
IN |
|
K
|
Kekrops SA
ATHEX:KEKR
|
GR |
|
Goldstone Technologies Ltd
NSE:GOLDTECH
|
IN |
|
I
|
Inbest Prime VI Inmuebles Socimi SA
MAD:YINB6
|
ES |
|
W
|
Westwater Resources Inc
AMEX:WWR
|
US |
|
A
|
Angi Inc
F:2UH
|
US |
|
M
|
Manning & Napier Inc
F:MN0
|
US |
|
Xinyi Solar Holdings Ltd
HKEX:968
|
CN |
|
Sumo Group PLC
LSE:SUMO
|
UK |
|
P
|
Pine Labs Ltd
NSE:PINELABS
|
IN |
|
TomTom NV
F:OEMB
|
NL |
|
Aurora Cannabis Inc
TSX:ACB
|
CA |
|
T
|
Tantalus Systems Holding Inc
TSX:GRID
|
CA |
|
Solar A/S
F:ZVR
|
DK |
|
U
|
UBM Development AG
VSE:UBS
|
AT |
Bankruptcy Probability
Medexus Pharmaceuticals Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Medexus Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Medexus Pharmaceuticals Inc
TSX:MDP
|
100.8m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
901.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
587.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
162.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Medexus Pharmaceuticals Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Medexus Pharmaceuticals Inc has total debt of 18.2m USD. This includes both short-term (0 USD) and long-term (18.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
